Delivery Order SPE2DB20D3101-SPE2DB24FRKF1
- Not listed
- This federal contract award, valued at $1,745.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sumatriptan 20 mg nasal sprays, with a performance period extending through March 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,565,827,998 units of Sumatriptan 20 mg nasal sprays. The firm-fixed-price delivery order contract has a ceiling value of $2,296.90 and an ultimate completion date of September 17, 2024. This award is not designated as a set-aside contract. Additionally, Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4566407817 units of Sumatriptan 20 mg nasal sprays. The $1,328.44 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 13, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sumatriptan 20 mg nasal sprays. The $1,718.58 firm fixed price delivery order has a completion date of September 9, 2024 and is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sumatriptan 5 mg nasal sprays. The contract, valued at $7,234.00, is a Firm Fixed Price Delivery Order with an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award is for the delivery of Sumatriptan 20 mg nasal sprays to the Defense Logistics Agency (DLA). The $1,216.86 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 22, 2022 and was awarded on February 18, 2022. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,115.39 Firm Fixed Price delivery order is for the supply of Sumatriptan 5 mg nasal sprays. This contract does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,692,724 units of Sumatriptan 20 mg nasal sprays. The $1,566.49 firm fixed-price contract was awarded on March 25, 2025 by the Defense Logistics Agency (DLA), with a period of performance ending on March 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $7,368.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sumatriptan 20 mg Nasal Sprays. It is a firm-fixed-price delivery order with a completion date of June 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with the ID SPE2DB22D3016|SPE2DB24FAEN8, is for the delivery of Sumatriptan 20 mg nasal sprays to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $7,417.04 and an ultimate completion date of December 1, 2023. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRKF1Delivery Order
This federal contract award is for the delivery of Sumatriptan 20 mg nasal sprays to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,617.92 and a completion date of May 14, 2024. It was awarded on May 13, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/13/24 |